Troxevasin, capsules 300mg 100pcs

Composition

of 1 capsule:

– troxerutin 300 mg

Auxiliary substances:

lactose monohydrate – 47 mg,

magnesium stearate-3 mg.

Shell composition:

quinoline yellow dye (E104) – 0.9%,

sunset yellow dye (E110) – 0.039%,

titanium dioxide (E171) – 3%,

gelatin-up to 100%.

Pharmacological action

Pharmaceutical group:

angioprotective agent.

Pharmaceutical action:  

Troxevazine is a mixture of hydroxyethyl derivatives of rutin, which is dominated by tri-hydroxyethylrutoside, which has P-vitamin activity. Troxevasin has a pronounced venotonic, capillarotonic, anti-exudative and hemostatic effect.

The drug reduces the permeability and fragility of capillaries, has an anti-edematous and anti-inflammatory effect. It blocks the venodilating effect of histamine, bradykinin, and acetylcholine. It has an anti-inflammatory effect on the parovenous tissue, has a pronounced antiplatelet effect.

The drug does not have an embryotoxic, teratogenic or mutagenic effect.

Indications

• : Chronic venous insufficiency, postphlebitic syndrome, trophic disorders in varicose veins and trophic ulcers. As an auxiliary treatment after sclerotherapy of veins and removal of varicose nodes. Hemorrhoids (pain, exudation, itching, and bleeding).
• Venous insufficiency and hemorrhoids during pregnancy, starting from the second trimester.
• As an adjunct treatment of retinopathy in patients with diabetes mellitus, arterial hypertension and atherosclerosis.

Use during pregnancy and lactation

Troxevasin should be used during pregnancy (II and III trimesters) and during lactation if the expected benefit to the mother prevails over the possible risk to the fetus and child.

Contraindications

• Hypersensitivity to rutosides or other components of the drug.
• Pregnancy (I trimester).
• Peptic ulcer of the stomach and duodenum, chronic gastritis in the acute phase, children under three years of age (solid dosage form).

Use with caution (long-term use) in patients with renal insufficiency, children aged 3 to 15 years

Side effects

Possible: allergic reactions, erosive and ulcerative lesions of the gastrointestinal tract, headache.

Interaction

The effect is enhanced with simultaneous use of ascorbic acid.

How to take, course of use and dosage

Inside, at the beginning of treatment,1 capsule is prescribed 2 times/sutai (morning and evening), with maintenance therapy-1 capsule/day for 3-4 weeks or more.

With retinopathy, the drug is prescribed 1-2 capsules 3 times a day.

Capsules should be taken with a meal.

Overdose

If you overdose, you may experience the following symptoms: agitation, nausea, headache, flushes of blood to the face.

In case of overdose, patients should wash their stomach, take activated charcoal, and start symptomatic treatment if necessary.

Special instructions

The use of Troxevasin is possible as one of the components of complex treatment.

Form of production

Troxevasin capsules are solid gelatin, size # 1, cylindrical, yellow in color; the contents of the capsules are powder from yellow to yellow-green in color, conglomerates are allowed, which disintegrate when pressed.

Storage conditions

Store in a dry place, protected from light, at a temperature not exceeding 25 °C

Shelf life

5 years

Active ingredient

Troxerutin

Dosage form

Capsules

Description

Pregnant women in the second and third trimester as prescribed by a doctor, For adults

Indications

Thrombophlebitis, Swelling after injuries and operations, Varicose veins, Dermatitis